European Companies Search Engine

EU funding (€9,875,071): Preventing lifetime obesity by early risk-factor identification, prognosis and intervention Hor1 May 2023 EU Research and Innovation programme "Horizon"

Text

Preventing lifetime obesity by early risk-factor identification, prognosis and intervention

Obesity is one of the main population health threats worldwide, with a sustained increase in prevalence over the last decades and a constellation of co-morbidities that seriously hamper individual wellbeing and life-expectancy. Despite major research efforts, obesity treatments have proven of limited efficacy. Thus, effective prevention strategies are essential to avoid the full spectrum of metabolic complications of overweight during the life-course. Adult obesity is rooted on early maturational events, including pathophysiological and psychological determinants occurring during the gestational, infantile and/or adolescent periods, which globally remain ill defined. Identification of such early pathogenic mechanisms and markers of metabolic disease is key for active prevention and personalized management of body weight disorders later in life. Of note, pathogenic mechanisms and susceptibility to obesity are seemingly gender-dependent, but this aspect remains underexplored and may compromise effectiveness of preventive measures and treatments tackling obesity and its complications. eprObes (for early Prevention of Obesity) is a multidisciplinary, patient-centered project, involving clinical studies targeting different maturational windows, coupled with cognitive, mental health, life-style and behavioral studies, as well as mechanistic analyses in suitable preclinical models, whose major aim is to define effective strategies for active prevention of obesity during the life-course, with particular focus on early developmental events, from prenatal (including peri-conceptional) to pubertal periods, and determinants of feeding behaviors. Multi-omics studies and integral analysis of eprObes data, assisted by bioinformatic technologies and artificial intelligence, will permit definition of tailored preventive measures and life-style interventions, at key maturational periods, to avoid excessive body weight gain and lifetime metabolic complications in both sexes.


Funded Companies:

Company name Funding amount
Agencia Estatal Consejo Superior de Investigaciones Cientificas €566,139
Amaris Espana Estrategia e Innovacion Tecnologica SL €0.00
Amaris France SAS €0.00
Amaris Research Unit €790,679
Consorcio Centro de Investigacion Biomedica en Red M.P €2,718,250
Eberhard Karls Universitaet Tuebingen €686,662
Fundacio Institut D'Investigacio Biomedica de Bellvitge €0.00
Fundacion Hospital General Universitario para La Investigacion Biomedica Docencia y Desarrollo de Las Ciencias de La Salud €0.00
Fundacion para La Investigacion Biomedica de Cordoba €0.00
Fundacion para La Investigacion del Hospital Clinico de La Comunitat Valenciana, Fundacion Incliva €0.00
Hipertansiyon VE Ateroskleroz Dernegi €416,938
Institut National de la Sante et de la Recherche Medicale €651,443
Paris Labs €0.00
Premium Research SL €490,808
Region Hovedstaden €1,155,573
Sihtasutus Tallinna Lastehaigla €0.00
Universidad de Cordoba €0.00
Universitat de Valencia €480,073
Universite de Liege €661,279
Uniwersytet Jagiellonski €440,969
Uniwersytet Rzeszowski €409,324
Vilniaus Universiteto Ligonine Santaros Klinikos €406,938

Source: https://cordis.europa.eu/project/id/101080219

The filing refers to a past date, and does not necessarily reflect the current state.